Quebec City, May 9, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS) an innovator in sterilization technology for medical devices in healthcare settings, is pleased to announce the appointment of Mr. Benoît Deschamps to the position of Chief Financial Officer and Vice President of Finance, effective June 15, 2011.
Quebec City, May 2, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS) will report first quarter (Q1) 2011 financial results, for the period ending March 31, 2011 and hold its fiscal 2010 Annual General Meeting of Shareholders on Wednesday May 11, 2011.
Quebec City, March 16, 2011 – TSO3 Inc. (“TSO3”) an innovator in sterilization technology for medical devices in healthcare settings using ozone, today reported sales for the fiscal year ending December 31, 2010 totalling $939,285 representing the sale of four new generation sterilizers (3M™ Optreoz™ 125-Z) to 3M™ for training purposes. This compares to $1.3 million the previous year for the sale of the first generation sterilizers sold directly to end-users (TSO3 STERIZONE® 125L).
Quebec City, March 7, 2011 – TSO3 Inc. (“TSO3”) (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings using ozone, today announced that it will report the Company’s annual financial results ending December 31, 2010, on Wednesday, March 16, 2011. TSO3 will host a conference call at 10:30 A.M. (EDST) the same day.